ArticleMolecular therapy. Oncology2025
Engineered oncolytic virus OH2-FLT3L enhances antitumor immunity via dendritic cell activation.
Duo Wan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it